Decreased microglial activation in MS patients treated with glatiramer acetate

@article{Ratchford2011DecreasedMA,
  title={Decreased microglial activation in MS patients treated with glatiramer acetate},
  author={John N. Ratchford and Christopher J. Endres and Dima A. Hammoud and Martin G. Pomper and Navid Shiee and John B McGready and Dzung L. Pham and Peter A. Calabresi},
  journal={Journal of Neurology},
  year={2011},
  volume={259},
  pages={1199-1205}
}
Activated microglia are thought to be an important contributor to tissue damage in multiple sclerosis (MS). The level of microglial activation can be measured non-invasively using [11C]-R-PK11195, a radiopharmaceutical for positron emission tomography (PET). Prior studies have identified abnormalities in the level of [11C]-R-PK11195 uptake in patients with MS, but treatment effects have not been evaluated. Nine previously untreated relapsing-remitting MS patients underwent PET and magnetic… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS
34 Citations
34 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 34 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 34 references

Cortical microglial activation is associated with disability in secondary progressive multiple sclerosis: an in vivo imaging study

  • M Politis, P Giannetti, +7 authors P Piccini
  • Neurology 74:A290
  • 2010
1 Excerpt

Similar Papers

Loading similar papers…